Autoimmune Diseases Overview
Autoimmune Diseases Overview
Autoimmunity is not a disease. It is a direction the immune system can take — turning against tissue it exists to protect — and where that lands decides everything that follows: which symptom a person notices first, which clinic they are referred to, and which test finds it. This guide is built around three things most people are never told: that one mechanism can settle in a joint, the skin, a kidney, the thyroid or the gut; that an antibody result is a clue rather than a verdict; and that treatment aims to hold inflammation below the line where organs are damaged, not to make a blood test negative.
-
A mechanism, not a disease
the same process can settle in a joint, the skin, a kidney, the thyroid or the gut
-
Antibodies are clues
a positive result occurs in healthy people too, and a negative one does not exclude the diagnosis
-
Read together, never alone
antibodies plus the clinical picture plus imaging or tissue — no single item is enough
-
Since the hospital was founded
our traditional Chinese medicine department, whose senior physicians see patients at our Guoyi Hall
Autoimmunity is a mechanism, not a single disease
The immune system's job is to tell the difference between what belongs to the body and what does not, and to attack only the second. Autoimmunity is what happens when that distinction breaks down: the system treats something in the body's own tissue as a target, produces antibodies or cells against it, and mounts the inflammatory response it usually reserves for an infection. Nothing has entered the body. The response itself is the disease.
That is why “autoimmune disease” is not a diagnosis in the way pneumonia is. It is a description of a direction the immune system has taken, and on its own it says nothing about where the inflammation is. The same process can settle in a joint, in the skin, in the filtering units of a kidney, in the thyroid or in the bowel. Two people with the same mechanism can have almost nothing in common in what they feel, who they are sent to see, and which test finds it.
Nor is it a weak immune system — if anything the reverse. That matters practically: the treatments that work dampen a specific part of the response, and a person on them is more vulnerable to infection than before the diagnosis, as set out on the treatment page.
| Step | What happens | What it explains |
|---|---|---|
| Loss of tolerance | The immune system stops treating a component of the body's own tissue as self | Why the process can run for years with nothing entering the body, and why removing an exposure rarely switches it off |
| Autoantibodies and immune complexes | Antibodies are produced against the body's own components; the complexes they form can be deposited in tissue | Why a blood test can detect the process at all, and why the antibody is a marker rather than the thing doing the damage |
| Inflammation | Inflammatory cells are recruited and release the signals that produce swelling, pain, fever and tissue injury | Why symptoms flare and settle rather than staying constant, and why treatment that modifies the immune response is where the benefit lies |
| Damage | Sustained or repeated inflammation is replaced by scar tissue and by loss of function | Why early effective treatment matters more than later treatment, and why some loss cannot be recovered once it has happened |
The last row is the reason the timing of diagnosis is not an academic concern. Inflammation is what treatment can still influence; damage is what has already been done. Those are two different things, and the whole aim of treatment is to intervene while it is still the first one.
One mechanism, many addresses — and why the first clinic is often not the right one
The organ the process lands on decides almost everything practical: what a person notices first, which clinic they walk into, and how long it takes before anyone puts the pieces together. The first clinic is usually the one that matches the symptom, not the one that matches the mechanism.
| Where it lands | What it looks like | Who usually sees it first |
|---|---|---|
| Joints | Symmetrical swelling and stiffness of the small joints, worst on waking, easing as the day goes on | Orthopaedics or physiotherapy, rather than the specialty that treats the mechanism |
| Skin and mucous membranes | A rash that does not behave like eczema, one that appears or worsens in sunlight, mouth ulcers that keep returning, or patches of changed colour | Dermatology, where the rash is treated as a skin problem until something else explains it |
| Kidneys | Swelling of the legs or around the eyes, urine that has become frothy, blood pressure that has become harder to control | Nephrology — and where a named condition emerges, it has its own guide: lupus nephritis and IgA nephropathy |
| Thyroid | Fatigue, cold intolerance and weight change, or the reverse; often found by a blood test before anything is felt | Endocrinology, covered in its own right in the thyroid disorders guide |
| Bowel | Diarrhoea that does not settle, blood in the stool, abdominal pain with weight loss | Gastroenterology, usually after an infectious cause has been excluded |
| Blood and blood vessels | A low platelet or white cell count found incidentally, clots, or recurrent pregnancy loss | Haematology, or obstetric medicine, sometimes years before anything else declares itself |
| Nowhere in particular | Fever that recurs, unintended weight loss, profound fatigue, night sweats | Often no door at all — and this is the group that waits longest |
The last row deserves more attention than it gets. When inflammation has an address, it gets referred. When it presents as fever, weight loss and exhaustion, it is investigated one symptom at a time, and the possibility that a single mechanism explains all three may not be raised until several normal results have accumulated.
So “which specialist do I need” is often the wrong first question. What is needed is a clinician willing to hold the whole picture — the joints, the rash and the blood count together — and ask whether one process explains them.
Antibodies are clues, not verdicts
Autoantibodies are the part of the blood test people remember, and they are the part most often read wrongly, in both directions. An autoantibody is a marker that the immune system has lost tolerance to something. It is not proof that a disease is present, and its absence is not proof that one is not.
Three facts sit behind that. Autoantibodies occur in people with no autoimmune disease, and more often as people get older. They can appear years before any symptom. And their level says nothing about how active a disease is: well-controlled disease with a high titre, and active disease with a low one, are both ordinary.
| The result | What it does say | What it does not say |
|---|---|---|
| A positive autoantibody | That the immune system recognises a component of the body's own tissue | That a disease is present, or which one, or how active it is |
| A titre measured twice on the same assay | Whether the immune response has changed between those two dates | That the disease is worsening — titres are not the measurement treatment is adjusted against |
| A negative autoantibody | That this antibody was not detected on this occasion | That an autoimmune disease is excluded: some forms are seronegative, some antibodies appear later, and assays differ |
| Several antibodies together | That the differential narrows, because some patterns cluster with particular conditions | That the clinical picture can be skipped — the pattern still has to be turned into a diagnosis |
What the result is for, then, is to be read with something else. The diagnosis is made by combination: the antibody, the clinical picture it was drawn to explain, and where necessary an image or a piece of tissue. No one of them is enough — as set out on the diagnosis page.
The target is the line below which organs are not being damaged
The question people ask about treatment is whether the antibody will become negative. It usually will not, and that is not the aim. The aim is to hold inflammation below the level at which it damages tissue.
That is worth saying explicitly, because the misunderstanding runs both ways and both do harm. One person sees a titre fall, concludes the disease has gone, stops the medicine, and the inflammation returns — often in the organ being protected. Another sees a titre that has not moved, concludes the treatment is not working, and abandons a regimen doing exactly what it was prescribed to do.
What is measured instead is a short list: are symptoms present, is the organ at risk still doing its job, are the acute-phase markers elevated, has imaging changed. Those four, read together at a stated interval, are what a treatment decision rests on. The interval is not a detail — most of these medicines take weeks to months to reach full effect, so a change cannot be judged in the fortnight after it is made.
The distinction that makes this concrete is between activity and damage. Activity is the inflammation happening now, and it is what treatment can change. Damage is what that inflammation has already left behind — scarring, reduced function — and it is cumulative and largely permanent. A plan that keeps activity below the line protects the function a person still has; it cannot restore what has gone. How the target is set and re-measured is on the treatment page.
What a full assessment contains
An assessment for suspected autoimmune disease has three jobs: decide whether the process is present, decide which organ or organs are involved and how much, and establish a baseline against which later measurements mean something. A consultation that produces a prescription without the first two has skipped what makes the prescription appropriate.
| Test or step | The question it answers |
|---|---|
| An autoantibody panel, requested for a specific reason | Is the immune system recognising the body's own tissue, and in which pattern? Requested because the history points somewhere — not as a screening exercise |
| Acute-phase reactants — erythrocyte sedimentation rate and C-reactive protein | Is inflammation active now, and roughly how much? These track activity; they do not diagnose anything |
| A full blood count | Is the blood involved — anaemia, a low white cell count, a low platelet count? Also the baseline later monitoring depends on |
| Organ function tests, chosen for the organ at risk — kidney function and urine, liver tests, thyroid function | Is the organ the mechanism may have landed on still doing its job, and is there a baseline to compare against later? |
| Imaging of the organ involved | What does the tissue look like now — inflammation, fluid, scarring? Establishes the structural baseline |
| A tissue sample, where the result would change management | What is actually happening in the tissue? In several conditions this is the only thing that separates two diseases that look identical in blood |
| A review of vaccination status and of what is due | Can the vaccines that have to be given before immunosuppression be given now? Live vaccines once treatment has started are a different and harder question |
Two things about that list are worth noticing. The antibody panel is not a screening test: ordering it in someone with no suggestive history produces results that are hard to interpret and usually lead to more testing rather than to an answer. And the infection screen and vaccination review are not administrative steps — they are what makes immunosuppressing treatment safe to start.
Where the mechanism lands on the thyroid, that part of the assessment belongs to our endocrinology department, whose subspecialty structure covers thyroid disease alongside diabetes, obesity and metabolic disease, pituitary, adrenal and gonadal disease, and bone metabolism. Thyroid function testing and thyroid ultrasound are carried out there, and where a nodule needs characterising the department performs thyroid nodule aspiration. Two endocrinologists lead that work: Dr Jiang Yiwen, whose published interests are thyroid disease and diabetes with its complications, and Dr Li Meng, whose published interests include thyroid disease, diabetic complications, secondary hypertension, uric acid disorders and gout, and pituitary and adrenal disease.
Why patients come to China for autoimmune assessment
What international patients come for is almost never a medicine unavailable at home — the drug classes used here are the same everywhere. It is the assembly, and in autoimmunity the assembly is where most of the delay is lost: a history taken across organs rather than within one; an antibody result read with its pattern and titre rather than as a single word; the organ at risk identified and measured, so a baseline exists before treatment begins; and a written target with the interval at which it will be re-measured, so the plan survives the trip home.
Our hospital is a Class A tertiary general hospital with more than sixty years behind it. Its traditional Chinese medicine department has been in place since the hospital was founded, and our Guoyi Hall is where senior physicians recognised at national and Guangdong provincial level see patients. Integrated Chinese and Western medicine is a designated specialty in Chancheng district, oriented towards sub-health and towards preventing recurrence in long-term conditions. Acupuncture and tuina, including traditional tendon-regulating methods and Qing-dynasty bone-setting techniques, draw patients from Europe, North America, Hong Kong, China and Macao, China, and one-finger Zen massage is national intangible cultural heritage.
Where a patient wants a combined approach, the position we would want stated to us is this one. It is an addition to the treatment the specialist has prescribed, not a substitute for it: the measurements continue on the same schedule, so any effect is visible rather than assumed, and anything taken has to be known to the clinician managing the condition, because herbs and supplements interact with prescribed medicines.
Where the assessment needs a rheumatology specialist, that is arranged as a specialist opinion, and the written plan names who is responsible for each part.
Most of the assessment can be established before travel is arranged. Sending the antibody results with pattern, titre and reference range, the blood counts and organ function tests with dates, any imaging or biopsy reports, everything you take, and a note of what has been tried lets a clinician say whether the pieces have been put together and which missing test is worth doing where you are. How to send that is on the practical questions page.